Actively Recruiting
Study of Bone Health, Fractures, and Treatment in Adults with Duchenne Muscular Dystrophy
Led by Istituto Giannina Gaslini · Updated on 2026-10-22
200
Participants Needed
15
Research Sites
43 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults with Duchenne muscular dystrophy DMD, a genetic disorder that causes progressive muscle weakness and complications like respiratory and heart problems, osteoporosis, and fractures. The study aims to better understand bone health issues in this population by examining the prevalence of fragility fractures, childhood risk factors, fracture treatments, bone metabolism markers, and genetic factors linked to fracture risk. About 200 adults with DMD aged 18 to 44 will be recruited from specialized centers, along with a control group of healthy males over 18 who will provide blood samples. Participants with DMD will undergo respiratory and orthopedic assessments, motor and upper-limb function tests, walking capacity evaluation, spine X-rays, and bone density scans. Blood samples will be collected for biochemical and genetic analyses. During the study, clinical history and medical data will be collected and anonymized. Researchers will analyze bone health, fracture prevalence, treatment patterns, and related biochemical and genetic markers. The study will measure lung function, spinal deformities, motor abilities, and bone density. The findings aim to improve fracture prevention and bone health management in adults with DMD. Participation involves assessments and sample collection at specialized centers, with data protection ensured.
CONDITIONS
Brief Title
Bone Health in Adults With Duchenne Muscular Dystrophy: A Survey on Osteoporosis, Fractures and Treatment.
Research Team
C
Chiara Panicucci
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here